Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur Radiol. 2003 Dec;13(12):2688-98. Epub 2003 Jun 19.

Currently used non-specific extracellular MR contrast media.

Author information

  • 1Department of Radiology, University Paris XI, University Hospital Paul-Brousse AP-HP, 12 avenue Paul Vaillant-Couturier, 94804 Villejuif, France. marie-france.bellin@pbr.ap-hop-paris.fr

Abstract

Magnetic resonance contrast agents have demonstrated their clinical usefulness in a variety of organs for improved detection of various neoplastic, inflammatory and functional abnormalities. Gadolinium chelates are the most widely used. They are extracellular, non-specific contrast agents. Their use in many clinical indications is justified because, in conjunction with improved imaging techniques, these safe and image-enhancing contrast agents add morphologic and functional information compared with unenhanced MR images. This article describes the commercially available compounds, and summarizes their approval status on the international market regarding indications and doses. Their mechanisms of action, biodistributions, toxicities and tolerance profiles in normal and high-risk patient populations are described. Additionally, this article reviews the specific recommendations by the manufacturers for patients at risk. Finally, their main clinical applications are reviewed.

PMID:
12819914
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk